期刊文献+

硝普钠联合多巴胺持续静脉泵入对老年顽固性心衰的效果及安全性 被引量:5

下载PDF
导出
摘要 目的:探讨硝普钠联合多巴胺持续静脉泵入对老年顽固性心衰的效果及安全性。方法:选择在本院接受治疗的老年顽固性心衰患者88例进行研究,随机分组各44例,对照组为硝普钠治疗,观察组增加多巴胺持续静脉泵入治疗,观察两组疗效、用药安全性。结果:观察组治疗有效率为95.45%,显著高于对照组的72.73%,P<0.05;观察组与对照组不良反应发生率分别为6.81%、4.55%,差异不显著,P>0.05;治疗后,两组心功能指标明显改善,观察组优于对照组,P<0.05。结论:在老年顽固性心衰治疗中选择硝普钠联合多巴胺持续静脉泵入可有效改善不良症状,提高治疗效果,且具有较高的安全性,不会增加不良反应发生率,值得推广。
作者 马新忠
出处 《北方药学》 2018年第12期157-158,共2页 Journal of North Pharmacy
  • 相关文献

参考文献8

二级参考文献66

  • 1徐中林,赵义发,吴兰兰.硝普钠临床应用的有效性和安全性回顾性分析[J].重庆医科大学学报,2006,31(1):110-112. 被引量:6
  • 2胡欣,徐岩,史学功,吴继雄,汪太平,于芳,程自平.CystatinC、Hcy及TNF-α在慢性心力衰竭患者血清中的表达变化[J].中国现代医学杂志,2006,16(23):3604-3606. 被引量:9
  • 3黄竞,刘芳,翟所迪.硝普钠致氰化物中毒及其防治[J].药物不良反应杂志,2007,9(4):267-271. 被引量:21
  • 4Mebazaa A,Yilmaz MB,levy P,et al.Recommendations on prehospital&early hospital management of acute heart failure:a consensus paper from the Heart Failure Association of the European Society of Cardiology,the European Society of Emergency Medicine and the Society of Academic Emergency Medicine[J].Eur J Heart Fail,2015,17:544-558.
  • 5Recombinant Human Brain Natriuretic Peptide Multicenter Clinical Study Group,Hu DY.Efficacy and safety of intravenous recombinant human brain natriuretic peptide in patients with decompensated acute heart failure:a multicenter,randomized,open label,controlled study.Zhonghua Xin Xue Guan Bing Za Zhi,2011,39:305-308.
  • 6Jia Z,Guo M,Zhang LY,et al.Levosimendan and nesiritide as a combination therapy in patients with acute heart failure.Am J Med Sci,2015,349:398-405.
  • 7Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2013,62:e147-e239.
  • 8FONAROW G C, ABRAHAM W T, ALBERT N M, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF [J]. Arch Intern Med, 2008, 168(8) : 847-854.
  • 9GRINES C L. Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure : A report from the cardiovascular and renal advisory panel of the food and drug administration [J]. Circulation, 2000, 101 (21) : E200-E201.
  • 10KEATING G M, GOA K L. Nesiritide: A review of its use in acute decompensated heart failure [ J ]. Drugs, 2003, 63 ( 1 ) : 47-70.

同被引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部